Opendata, web and dolomites

Baby Beat TERMINATED

Providing Clarity of Fetus Heartbeat Through Baby Beat Bracelet Measuring Fetal Arterial Pulse Wave

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "Baby Beat" data sheet

The following table provides information about the project.

Coordinator
BCB Informatica y Control S.L. 

Organization address
address: Calle Fernando el Catolico 11/2B DCHA
city: Madrid
postcode: 28015
website: www.bcb.es

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 1˙091˙515 €
 EC max contribution 764˙060 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-2-2014
 Funding Scheme /SME-2
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2017-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BCB Informatica y Control S.L. ES (Madrid) coordinator 764˙060.00

Mappa

 Project objective

Baby Beat represents our innovative response to the declining birthrate, increasing pregnancy risks and risks related to the generally higher age of pregnant women. It consists of a bracelet with integrated non-invasive technology that continuously measures the fetal heartbeat 24 hours, 7 days a week from around Week 20 of the pregnancy. This wearable device communicates with smart phones via Bluetooth and generates automatic alarms when the fetal heartbeat exceeds specific thresholds. The main innovations are that this method is non-invasive unlike all other devices available on the market and that it will be available at an attainable price of a few hundred euros. The overall objective of Phase II is to miniaturize the existing prototype, to test and demonstrate its usefulness on a larger group of pregnant women in clinical trials, and to obtain the necessary certifications for Baby Beat to become a medical device. The market size for Baby Beat is promising when considering the number of pregnancies per year, following the trends of the prenatal retail market and considering the boom of non-invasive prenatal tests. There are 23 million pregnancies in the developed world itself. We will follow a two-tiered business model with direct sales through pharmacies and indirect sales through insurance companies, hospitals and clinics. This will allow us to boost our company growth and to create a significant amount of new jobs. With our medical device and software, we foster the prevention of prenatal problems, and facilitate the provision of personalized care: high risk cases do not remain undiscovered, risk patients only proceed with visits if Baby Beat indicates a need, risk patients do not need to be hospitalized and different agents of the healthcare system will better coordinated.

 Work performed, outcomes and results:  advancements report(s) 

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BABY BEAT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BABY BEAT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

SKYTUNEUP (2017)

SKYTUNEUP: THE ULTIMATE PLATFORM TO OPTIMIZE AND SECURE THE USE OF PUBLIC CLOUD TO ORGANIZATIONS

Read More  

Piql-GO (2018)

Ultra-secure data storage - and long-term preservation of digital and analogue data

Read More  

OE Scan (2018)

A next generation diagnostic device that effectively screens for breast cancer in all tissue types, without the use of ionising radiation

Read More